| The National
Institutes of Health and Funding for Renal Disease
Josephine Briggs, M.D. Simplified Pathophysiologic Approach to Renal Tubular Acidosis Thomas D. DuBose, Jr., M.D. Peritonitis in CAPD Stephen I. Vas, M.D. Nocturnal Hemodialysis. A New Alternative. Andreas Pierratos, M.D. Hemodialysis Adequacy Gerald Schulman, M.D. New Therapies for Acute and Chronic Renal Failure. H. David Humes, M.D. Treatment of Symptomatic Renal Stone Disease James Lingeman, M.D. Why Do We Reject Renal Grafts? Mohamed H. Sayegh, M.D. |
| Faculty |
| Josephine
Briggs, M.D. , Director, KUH Division, NIDDK, NIH, Bethesda, MD.
Thomas D. DuBose, Jr., M.D. , Professor of Medicine and Integrative Biology and Director of Renal Disease, Department of Medicine, University of Texas at Houston. H. David Humes, M.D. , Professor of Medicine and Chief, Department of Medicine, University of Michigan at Ann Arbor, MI. James Lingeman, M.D. , Director of Research, Methodist Hospital Institute for Kidney Stone Disease Andreas Pierratos, M.D. , Assistant Professor of Medicine, University of Toronto; Head of Dialysis, Wellesly Central Hospital, Toronto, Ontario, Canada. Mohamed H. Sayegh, M.D. , Associate Professor of Medicine, Harvard Medical School Director, Laboratory of Immunogenetics and Transplantation Research Brigham and Women's Hospital Gerald Schulman, M.D. , Associate Professor of Medicine, Vanderbilt University; Director of the End-Stage Renal Disease Program, Nashville, TN. Stephen I. Vas, M.D. , Professor of Medicine and Microbiology, Division of Nephrology, University of Toronto; Staff Physician, University of Toronto Hospital, Western Division. |